STAT+: Pharmalittle: We’re reading about a bill to overhaul the 340B program, a new FDA commissioner candidate, and more

Дата публикации: 26-06-2026 13:17:59

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans.…

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more	0	5	10-07-2026
2	STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more	0	5	02-07-2026
3	STAT+: Up and down the ladder: The latest comings and goings	0	5	26-06-2026
4	STAT+: Embryo editing advances reignite ethical debates	0	5	26-06-2026
5	STAT+: Cassidy proposes bill to rein in 340B drug discount program	0	5	25-06-2026
6	STAT+: 931 days. The drug approval scandal hiding in plain sight	0	5	09-07-2026
7	Taxation With Representation: Sidley, Paul Weiss, Kirkland	0	5	26-06-2026
8	BIO 2026: AI, federal policy impacts, and general vibes	0	5	26-06-2026
9	STAT+: Up and down the ladder: The latest comings and goings	0	2	02-07-2026
10	The mysterious case of Eli Lilly’s obesity drug	0	5	25-06-2026

Классификация: Мнения. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 3. Источник: www.statnews.com.